Bollore SE (BOLNV.PA) Stock Fundamental Analysis

Europe • Euronext Paris • EPA:BOLNV • FR001400XP40

5.247 EUR
-0.85 (-13.98%)
Last: May 30, 2025, 07:00 PM
Fundamental Rating

4

Taking everything into account, BOLNV scores 4 out of 10 in our fundamental rating. BOLNV was compared to 48 industry peers in the Entertainment industry. BOLNV has only an average score on both its financial health and profitability. BOLNV has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • BOLNV had positive earnings in the past year.
  • BOLNV had a positive operating cash flow in the past year.
  • Each year in the past 5 years BOLNV has been profitable.
  • BOLNV had a positive operating cash flow in each of the past 5 years.
BOLNV.PA Yearly Net Income VS EBIT VS OCF VS FCFBOLNV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

1.2 Ratios

  • With a decent Return On Assets value of 6.15%, BOLNV is doing good in the industry, outperforming 74.47% of the companies in the same industry.
  • The Return On Equity of BOLNV (14.99%) is better than 65.96% of its industry peers.
  • BOLNV has a Return On Invested Capital of 0.75%. This is comparable to the rest of the industry: BOLNV outperforms 44.68% of its industry peers.
Industry RankSector Rank
ROA 6.15%
ROE 14.99%
ROIC 0.75%
ROA(3y)4.32%
ROA(5y)4.84%
ROE(3y)7.64%
ROE(5y)11.75%
ROIC(3y)N/A
ROIC(5y)N/A
BOLNV.PA Yearly ROA, ROE, ROICBOLNV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

  • The Profit Margin of BOLNV (21.69%) is better than 91.49% of its industry peers.
  • In the last couple of years the Profit Margin of BOLNV has grown nicely.
  • BOLNV has a Operating Margin of 2.75%. This is comparable to the rest of the industry: BOLNV outperforms 53.19% of its industry peers.
  • With a Gross Margin value of 32.15%, BOLNV is not doing good in the industry: 74.47% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of BOLNV has declined.
Industry RankSector Rank
OM 2.75%
PM (TTM) 21.69%
GM 32.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y16.91%
PM growth 5Y127.48%
GM growth 3Y-44.39%
GM growth 5Y-31.55%
BOLNV.PA Yearly Profit, Operating, Gross MarginsBOLNV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BOLNV is destroying value.
  • BOLNV has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, BOLNV has less shares outstanding
  • Compared to 1 year ago, BOLNV has an improved debt to assets ratio.
BOLNV.PA Yearly Shares OutstandingBOLNV.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B
BOLNV.PA Yearly Total Debt VS Total AssetsBOLNV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • BOLNV has an Altman-Z score of 1.01. This is a bad value and indicates that BOLNV is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 1.01, BOLNV perfoms like the industry average, outperforming 51.06% of the companies in the same industry.
  • The Debt to FCF ratio of BOLNV is 5.74, which is a neutral value as it means it would take BOLNV, 5.74 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of BOLNV (5.74) is comparable to the rest of the industry.
  • BOLNV has a Debt/Equity ratio of 0.13. This is a healthy value indicating a solid balance between debt and equity.
  • BOLNV's Debt to Equity ratio of 0.13 is fine compared to the rest of the industry. BOLNV outperforms 70.21% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 5.74
Altman-Z 1.01
ROIC/WACC0.13
WACC5.85%
BOLNV.PA Yearly LT Debt VS Equity VS FCFBOLNV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B 20B 25B

2.3 Liquidity

  • A Current Ratio of 1.18 indicates that BOLNV should not have too much problems paying its short term obligations.
  • The Current ratio of BOLNV (1.18) is better than 68.09% of its industry peers.
  • BOLNV has a Quick Ratio of 1.08. This is a normal value and indicates that BOLNV is financially healthy and should not expect problems in meeting its short term obligations.
  • BOLNV has a better Quick ratio (1.08) than 63.83% of its industry peers.
Industry RankSector Rank
Current Ratio 1.18
Quick Ratio 1.08
BOLNV.PA Yearly Current Assets VS Current LiabilitesBOLNV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 700.00% over the past year.
  • BOLNV shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 51.57% yearly.
  • BOLNV shows a decrease in Revenue. In the last year, the revenue decreased by -1.39%.
  • The Revenue for BOLNV have been decreasing by -33.92% on average. This is quite bad
EPS 1Y (TTM)700%
EPS 3Y-32.27%
EPS 5Y51.57%
EPS Q2Q%-1460%
Revenue 1Y (TTM)-1.39%
Revenue growth 3Y-42.7%
Revenue growth 5Y-33.92%
Sales Q2Q%N/A

3.2 Future

  • Based on estimates for the next years, BOLNV will show a decrease in Earnings Per Share. The EPS will decrease by -4.24% on average per year.
  • The Revenue is expected to decrease by -46.45% on average over the next years. This is quite bad
EPS Next Y-34.15%
EPS Next 2Y1.21%
EPS Next 3Y-4.24%
EPS Next 5YN/A
Revenue Next Year-85.45%
Revenue Next 2Y-61.58%
Revenue Next 3Y-46.45%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BOLNV.PA Yearly Revenue VS EstimatesBOLNV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5B 10B 15B 20B
BOLNV.PA Yearly EPS VS EstimatesBOLNV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2024 2025 2026 2027 0.05 0.1 0.15

4

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 8.20, the valuation of BOLNV can be described as reasonable.
  • Compared to the rest of the industry, the Price/Earnings ratio of BOLNV indicates a rather cheap valuation: BOLNV is cheaper than 91.49% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.93. BOLNV is valued rather cheaply when compared to this.
  • The Price/Forward Earnings ratio is 57.72, which means the current valuation is very expensive for BOLNV.
  • The rest of the industry has a similar Price/Forward Earnings ratio as BOLNV.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.77, BOLNV is valued quite expensively.
Industry RankSector Rank
PE 8.2
Fwd PE 57.72
BOLNV.PA Price Earnings VS Forward Price EarningsBOLNV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • BOLNV's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of BOLNV indicates a somewhat cheap valuation: BOLNV is cheaper than 72.34% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 13.1
EV/EBITDA 8.16
BOLNV.PA Per share dataBOLNV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • BOLNV's earnings are expected to decrease with -4.24% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.16
EPS Next 2Y1.21%
EPS Next 3Y-4.24%

5

5. Dividend

5.1 Amount

  • BOLNV has a Yearly Dividend Yield of 1.51%.
  • BOLNV's Dividend Yield is rather good when compared to the industry average which is at 0.87. BOLNV pays more dividend than 87.23% of the companies in the same industry.
  • BOLNV's Dividend Yield is comparable with the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 1.51%

5.2 History

  • The dividend of BOLNV has a limited annual growth rate of 3.53%.
Dividend Growth(5Y)3.53%
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

  • BOLNV pays out 7.97% of its income as dividend. This is a sustainable payout ratio.
DP7.97%
EPS Next 2Y1.21%
EPS Next 3Y-4.24%
BOLNV.PA Yearly Income VS Free CF VS DividendBOLNV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B
BOLNV.PA Dividend Payout.BOLNV.PA Dividend Payout, showing the Payout Ratio.BOLNV.PA Dividend Payout.PayoutRetained Earnings

Bollore SE

EPA:BOLNV (5/30/2025, 7:00:00 PM)

5.247

-0.85 (-13.98%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)03-17
Earnings (Next)07-28
Inst Owners11.91%
Inst Owner ChangeN/A
Ins Owners5.66%
Ins Owner ChangeN/A
Market Cap14.74B
Revenue(TTM)3.13B
Net Income(TTM)3.91B
Analysts77.5
Price Target5.88 (12.06%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.51%
Yearly Dividend0.06
Dividend Growth(5Y)3.53%
DP7.97%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-11.59%
PT rev (3m)-11.59%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-41.3%
EPS NY rev (3m)-41.3%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-85.67%
Revenue NY rev (3m)-85.67%
Valuation
Industry RankSector Rank
PE 8.2
Fwd PE 57.72
P/S 0.82
P/FCF 13.1
P/OCF 8.85
P/B 0.56
P/tB 1.9
EV/EBITDA 8.16
EPS(TTM)0.64
EY12.2%
EPS(NY)0.09
Fwd EY1.73%
FCF(TTM)0.4
FCFY7.63%
OCF(TTM)0.59
OCFY11.29%
SpS6.42
BVpS9.3
TBVpS2.76
PEG (NY)N/A
PEG (5Y)0.16
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 6.15%
ROE 14.99%
ROCE 1.01%
ROIC 0.75%
ROICexc 0.88%
ROICexgc 1.59%
OM 2.75%
PM (TTM) 21.69%
GM 32.15%
FCFM 6.24%
ROA(3y)4.32%
ROA(5y)4.84%
ROE(3y)7.64%
ROE(5y)11.75%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y16.91%
PM growth 5Y127.48%
GM growth 3Y-44.39%
GM growth 5Y-31.55%
F-Score7
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 5.74
Debt/EBITDA 2.18
Cap/Depr 48.98%
Cap/Sales 2.99%
Interest Coverage 6.55
Cash Conversion 104.18%
Profit Quality 28.75%
Current Ratio 1.18
Quick Ratio 1.08
Altman-Z 1.01
F-Score7
WACC5.85%
ROIC/WACC0.13
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)13.01%
Cap/Sales(5y)9.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)700%
EPS 3Y-32.27%
EPS 5Y51.57%
EPS Q2Q%-1460%
EPS Next Y-34.15%
EPS Next 2Y1.21%
EPS Next 3Y-4.24%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.39%
Revenue growth 3Y-42.7%
Revenue growth 5Y-33.92%
Sales Q2Q%N/A
Revenue Next Year-85.45%
Revenue Next 2Y-61.58%
Revenue Next 3Y-46.45%
Revenue Next 5YN/A
EBIT growth 1Y17.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-81.29%
EBIT Next 3Y-32.79%
EBIT Next 5YN/A
FCF growth 1Y70.08%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y52.28%
OCF growth 3Y-52.89%
OCF growth 5Y-40.98%

Bollore SE / BOLNV.PA FAQ

What is the fundamental rating for BOLNV stock?

ChartMill assigns a fundamental rating of 4 / 10 to BOLNV.PA.


What is the valuation status of Bollore SE (BOLNV.PA) stock?

ChartMill assigns a valuation rating of 4 / 10 to Bollore SE (BOLNV.PA). This can be considered as Fairly Valued.


What is the profitability of BOLNV stock?

Bollore SE (BOLNV.PA) has a profitability rating of 5 / 10.


What is the expected EPS growth for Bollore SE (BOLNV.PA) stock?

The Earnings per Share (EPS) of Bollore SE (BOLNV.PA) is expected to decline by -34.15% in the next year.


Can you provide the dividend sustainability for BOLNV stock?

The dividend rating of Bollore SE (BOLNV.PA) is 4 / 10 and the dividend payout ratio is 7.97%.